Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1980
Hepatic nuclear free and engaged RNA-polymerases in young rats pretreated with 3-methylcholanthreneU Kleeberg, J Szeberényi, P Juhasz, et al.
Biochemical Pharmacology|March 15, 1982
Influence of 3-methylcholanthrene on liver nucleolar and nucleoplasmic activities of protein kinases and RNA polymerasesU Kleeberg, J Szeberényi, P Juhasz, et al.
Acta Biologica Et Medica Germanica|January 1, 1975
On the selectivity of aryl hydrocarbon hydroxylase induction after 3-methylcholanthrene pretreatmentU Kleeberg, A Barth, J Roth, et al.
Acta Biologica Academiae Scientiarum Hungaricae|January 1, 1980
Effect of 3-methylcholanthrene on RNA polymerase and protein kinase activities and on the nuclear ultrastructure of rat liverA Tigyi, J Szeberényi, L Komáromy, et al.
Cancer|November 1, 1986
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO)H E Wander, G A Nagel, H C Blossey, et al.
Experimental Pathology|January 1, 1991
The influence of "essential" phospholipids (EPL) on phase-I- and phase-II-reactions and on the glutathione status in the liver of aging ratsW Klinger, D Müller, U Kleeberg, et al.
Scandinavian Journal of Haematology|December 1, 1975
Congenital stomatocytosis and chronic haemolytic anaemiaU Bienzle, D Niethammer, U Kleeberg, et al.
Onkologie|August 1, 1982
[Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer]H C Blossey, H E Wander, G A Nagel, et al.
Chemical Research in Toxicology|December 22, 1998
Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantificationR Frötschl, L Chichmanov, U Kleeberg, et al.
Onkologie|August 1, 1982
[High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration]H C Blossey, H E Wander, G A Nagel, et al.
Pageof 3